Investing Profile

Isaac Manke

InvestorVC
Partner at Acorn Bioventures
Photo of Isaac Manke, Partner at Acorn Bioventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
OnKure Therapeutics
Post Ipo EquityOct 2024$65M
Series CMay 2023$54M
Series BMar 2021$57M
$180M
Q32 Bio
Post Ipo EquityMar 2024$42M
Series BOct 2020$60M
$150M
Co-investors: Diyong Xu (OrbiMed), David Grayzel (Atlas Venture)
ONK Therapeutics
Series AJan 2022$22M
$22M
True North Therapeutics
Series CDec 2015$40M
$40M